FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2066991639> ?p ?o ?g. }

• W2066991639 abstract "Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CAIntroduction: A significant number of histologically triple negative breast cancer (TNBC) cells express substantial estrogen receptor (ER) mRNA but do not express ER protein as a result of rapid proteolytic degradation. Here we assessed whether proteasome inhibitors could sensitize such cells to tamoxifen-induced growth suppression. Methods: Data from the Katzenellenbogen laboratory elegantly demonstrate that in high ER mRNA MDA-MB-468 cells, ER protein is rapidly degraded via proteosomal degradation (Bhatt et al. MCB , 2012).Utilizing established human TNBC cell lines that express high ER mRNA (BT-20, MDA-MB-468, and newly established human TNBC cell lines from our laboratory MCJB2 and MCJB11), we defined a therapeutic strategy using the proteasome inhibitor carfilzomib in combination with the antiestrogen tamoxifen that demonstrates antitumor synergy. Results: We found that administration of carfilzomib in TNBC cell lines with high ER mRNA restored ER protein expression, and that combining this treatment with tamoxifen treatment led to enhanced growth suppression. We found that the TNBC MDA-MB-231 cells, which express no ER mRNA, show some growth suppression, but that tamoxifen provided no further growth suppression with these cells. We have previously shown that combined epigenetic therapy [methyltransferase inhibitor (decitabine) plus a histone deacetylase inhibitor (HDACi; romidepsin)] provided antitumor synergy in MDA-MB-231 cells via upregulation of the soluble Wnt suppressor, secreted frizzled protein 1 (sFRP1; Cooper et al. CCR , 2012). In addition, we show that this epigenetic therapy restores silenced ER mRNA and protein levels in MDA-MB-231 cells, and that combination of this epigenetic therapy with tamoxifen in MDA-MB-231 cells led to enhanced growth suppression by tamoxifen. We are currently testing these therapeutic strategies in vivo using established TNBC cell lines and our newly developed patient derived xenograft (PDX) mouse models that express either ERhigh or ERlow mRNA. Conclusions: If validated in animal models, we propose that ER mRNA expression level in TNBC patients could guide therapeutic choice, whereby, ERlow mRNA TNBC tumors could respond to epigenetic therapy followed by antiestrogen while ERhigh mRNA TNBC tumors could respond to a proteosome inhibitor followed by antiestrogen therapy. These results identify a novel epigenetic biomarker as predictive of therapeutic response.Citation Format: Christina A. von Roemeling, Laura A. Marlow, James Miller, Adam Mathias, Louis Dawson, Steadman Harrison, Beth A. Hollister, Derek C. Radisky, John Alton Copland. Estrogen receptor mRNA-directed therapy for triple-negative breast cancer. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr LB-95. doi:10.1158/1538-7445.AM2014-LB-95" @default.
• W2066991639 created "2016-06-24" @default.
• W2066991639 creator A5000031123 @default.
• W2066991639 creator A5016606769 @default.
• W2066991639 creator A5048587108 @default.
• W2066991639 creator A5062435069 @default.
• W2066991639 creator A5077304523 @default.
• W2066991639 creator A5079740606 @default.
• W2066991639 creator A5082343299 @default.
• W2066991639 creator A5087686680 @default.
• W2066991639 creator A5091514582 @default.
• W2066991639 date "2014-09-30" @default.
• W2066991639 modified "2023-09-27" @default.
• W2066991639 title "Abstract LB-95: Estrogen receptor mRNA-directed therapy for triple-negative breast cancer" @default.
• W2066991639 doi "https://doi.org/10.1158/1538-7445.am2014-lb-95" @default.
• W2066991639 hasPublicationYear "2014" @default.
• W2066991639 type Work @default.
• W2066991639 sameAs 2066991639 @default.
• W2066991639 citedByCount "0" @default.
• W2066991639 crossrefType "proceedings-article" @default.
• W2066991639 hasAuthorship W2066991639A5000031123 @default.
• W2066991639 hasAuthorship W2066991639A5016606769 @default.
• W2066991639 hasAuthorship W2066991639A5048587108 @default.
• W2066991639 hasAuthorship W2066991639A5062435069 @default.
• W2066991639 hasAuthorship W2066991639A5077304523 @default.
• W2066991639 hasAuthorship W2066991639A5079740606 @default.
• W2066991639 hasAuthorship W2066991639A5082343299 @default.
• W2066991639 hasAuthorship W2066991639A5087686680 @default.
• W2066991639 hasAuthorship W2066991639A5091514582 @default.
• W2066991639 hasConcept C104317684 @default.
• W2066991639 hasConcept C121608353 @default.
• W2066991639 hasConcept C126322002 @default.
• W2066991639 hasConcept C172313692 @default.
• W2066991639 hasConcept C185592680 @default.
• W2066991639 hasConcept C203014093 @default.
• W2066991639 hasConcept C27740335 @default.
• W2066991639 hasConcept C2776067312 @default.
• W2066991639 hasConcept C2776202225 @default.
• W2066991639 hasConcept C2776262904 @default.
• W2066991639 hasConcept C2776364478 @default.
• W2066991639 hasConcept C2777176818 @default.
• W2066991639 hasConcept C2777478702 @default.
• W2066991639 hasConcept C2778305200 @default.
• W2066991639 hasConcept C2778367456 @default.
• W2066991639 hasConcept C2780108899 @default.
• W2066991639 hasConcept C2780110267 @default.
• W2066991639 hasConcept C2781462825 @default.
• W2066991639 hasConcept C2992195973 @default.
• W2066991639 hasConcept C502942594 @default.
• W2066991639 hasConcept C530470458 @default.
• W2066991639 hasConcept C55493867 @default.
• W2066991639 hasConcept C64927066 @default.
• W2066991639 hasConcept C71924100 @default.
• W2066991639 hasConcept C84606932 @default.
• W2066991639 hasConcept C86803240 @default.
• W2066991639 hasConcept C95444343 @default.
• W2066991639 hasConceptScore W2066991639C104317684 @default.
• W2066991639 hasConceptScore W2066991639C121608353 @default.
• W2066991639 hasConceptScore W2066991639C126322002 @default.
• W2066991639 hasConceptScore W2066991639C172313692 @default.
• W2066991639 hasConceptScore W2066991639C185592680 @default.
• W2066991639 hasConceptScore W2066991639C203014093 @default.
• W2066991639 hasConceptScore W2066991639C27740335 @default.
• W2066991639 hasConceptScore W2066991639C2776067312 @default.
• W2066991639 hasConceptScore W2066991639C2776202225 @default.
• W2066991639 hasConceptScore W2066991639C2776262904 @default.
• W2066991639 hasConceptScore W2066991639C2776364478 @default.
• W2066991639 hasConceptScore W2066991639C2777176818 @default.
• W2066991639 hasConceptScore W2066991639C2777478702 @default.
• W2066991639 hasConceptScore W2066991639C2778305200 @default.
• W2066991639 hasConceptScore W2066991639C2778367456 @default.
• W2066991639 hasConceptScore W2066991639C2780108899 @default.
• W2066991639 hasConceptScore W2066991639C2780110267 @default.
• W2066991639 hasConceptScore W2066991639C2781462825 @default.
• W2066991639 hasConceptScore W2066991639C2992195973 @default.
• W2066991639 hasConceptScore W2066991639C502942594 @default.
• W2066991639 hasConceptScore W2066991639C530470458 @default.
• W2066991639 hasConceptScore W2066991639C55493867 @default.
• W2066991639 hasConceptScore W2066991639C64927066 @default.
• W2066991639 hasConceptScore W2066991639C71924100 @default.
• W2066991639 hasConceptScore W2066991639C84606932 @default.
• W2066991639 hasConceptScore W2066991639C86803240 @default.
• W2066991639 hasConceptScore W2066991639C95444343 @default.
• W2066991639 hasLocation W20669916391 @default.
• W2066991639 hasOpenAccess W2066991639 @default.
• W2066991639 hasPrimaryLocation W20669916391 @default.
• W2066991639 hasRelatedWork W2001138013 @default.
• W2066991639 hasRelatedWork W2029477586 @default.
• W2066991639 hasRelatedWork W2049979386 @default.
• W2066991639 hasRelatedWork W2068022222 @default.
• W2066991639 hasRelatedWork W2139609805 @default.
• W2066991639 hasRelatedWork W2279208322 @default.
• W2066991639 hasRelatedWork W2328345356 @default.
• W2066991639 hasRelatedWork W2408482488 @default.
• W2066991639 hasRelatedWork W2560980306 @default.
• W2066991639 hasRelatedWork W2593028134 @default.
• W2066991639 hasRelatedWork W2593247253 @default.
• W2066991639 hasRelatedWork W2739970637 @default.
• W2066991639 hasRelatedWork W2740856811 @default.
• W2066991639 hasRelatedWork W2741869580 @default.

• next